It's been a couple of months since pharma’s annual JP Morgan Chase Healthcare Conference, where the mood around pharma M&A this year was optimistic, albeit with a few caveats. On today’s podcast, host Jonah Comstock is joined by Cody Powers, principal of portfolio and business development at ZS Associates, to discuss those trends and predictions and how they’re shaking out so far.
Pace, acceleration, and precision are the name of the game
Technology working as the puzzle piece to bring better outcomes to patients
Is precision psychiatry possible?
Encouraging early engagement to revitalise Europe’s pharmaceutical landscape
Predictions for AI in mental health in the coming year
Fixing clinical trial data management
Harnessing the velocity of biopharmaceutical advances
Conference report: Reuters Pharma USA
The future of AI: Machine learning working together with scientific expertise
Understanding the politics of drug pricing in the United States
Female leadership and lessening disease burden
The unique clinical trial challenges faced by digital therapeutics
The unmentionables: Challenging inequalities in women’s health
The next chapter for AI protein structure prediction
Avoiding the data swamp: The transformative power of AI
How natural language processing can make a difference in pharma
Transitioning from traditional surgical methods to the innovative use of stem cells.
Accelerating the process, transforming therapies and advancing precision medicine
Applying genetics to chemistry to find new small molecules
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Stuff To Blow Your Mind
Unexplainable
Speaking of Psychology